Clinical Trial Update: Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults [Phase 3]

View source ↗

Summary

A Phase 3 trial of Ecopipam for Tourette syndrome has completed, and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• Ecopipam (Ecopipam)

Snippet

Sponsor: Emalex Biosciences Inc. | Conditions: Tourette Disorder | Phase 3 | Status: COMPLETED | Results posted: 2025-11-25